Federico García Selected Research

oleuropeoside

12/2019

The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Federico García Research Topics

Disease

17	Infections 05/2021 - 01/2012
6	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 09/2005
5	COVID-19 01/2022 - 12/2020
5	Hepatitis C 01/2021 - 07/2018
4	Inflammation (Inflammations) 05/2022 - 01/2018
4	Obesity 05/2022 - 12/2019
4	Colitis 08/2021 - 01/2018
4	Viremia 01/2021 - 09/2005
4	Chronic Hepatitis C 01/2021 - 11/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2022 - 07/2019
3	Dysbiosis 05/2022 - 05/2018
2	Body Weight (Weight, Body) 05/2022 - 12/2019
2	Disease Progression 10/2021 - 05/2021
2	Insulin Resistance 01/2020 - 12/2019
2	HIV Infections (HIV Infection) 01/2019 - 12/2011
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2018 - 11/2018
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Weight Gain 07/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Epilepsy (Aura) 01/2020
1	Deglutition Disorders (Dysphagia) 01/2020
1	Paresis (Hemiparesis) 01/2020
1	Breast Neoplasms (Breast Cancer) 05/2019
1	Neoplasm Metastasis (Metastasis) 05/2019
1	Neoplasms (Cancer) 05/2019
1	Crohn Disease (Crohn's Disease) 12/2018
1	Hypertension (High Blood Pressure) 05/2018
1	Reinfection 11/2015
1	Chronic Hepatitis B 02/2011

Drug/Important Bio-Agent (IBA)

8	Antiviral Agents (Antivirals)IBA 01/2021 - 11/2015
5	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2005
4	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2018
3	LipidsIBA 05/2022 - 12/2019
3	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 01/2020
3	AntibodiesIBA 06/2021 - 04/2019
3	Pharmaceutical PreparationsIBA 01/2020 - 12/2011
3	Dextrans (Dextran)FDA Link 01/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2019
2	2,4-dinitrofluorobenzene sulfonic acidIBA 08/2021 - 01/2019
2	Sulfonic AcidsIBA 08/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 07/2019 - 12/2018
2	Dendrimers (Dendrons)IBA 01/2019 - 05/2013
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019 - 01/2018
1	Rosmarinic AcidIBA 05/2022
1	AntioxidantsIBA 05/2022
1	CreatinineIBA 01/2022
1	Cytokine Receptor gp130IBA 01/2022
1	HLA-C Antigens (HLA-C)IBA 10/2021
1	DinitrobenzenesIBA 08/2021
1	LeptinIBA 07/2021
1	AdiponectinIBA 07/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2021
1	CytokinesIBA 07/2021
1	OccludinIBA 07/2021
1	NucleoproteinsIBA 06/2021
1	Immunoglobulin A (IgA)IBA 06/2021
1	Immunoglobulin G (IgG)IBA 06/2021
1	Immunoglobulin M (IgM)IBA 06/2021
1	Proteins (Proteins, Gene)FDA Link 06/2021
1	Ribavirin (Virazole)FDA LinkGeneric 01/2021
1	velpatasvirIBA 01/2021
1	SofosbuvirIBA 01/2021
1	glecaprevir and pibrentasvirIBA 01/2021
1	voxilaprevirIBA 01/2021
1	Nucleic AcidsIBA 12/2020
1	AntigensIBA 01/2020
1	HDL CholesterolIBA 01/2020
1	doravirineIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Viral RNAIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	PrebioticsIBA 01/2020
1	oxidized low density lipoproteinIBA 01/2020
1	oleuropeosideIBA 12/2019
1	olive leaf extractIBA 12/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2019
1	Endocrine DisruptorsIBA 05/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	IntegrasesIBA 01/2019
1	carbosilaneIBA 01/2019
1	2,4-dinitrobenzeneIBA 01/2019
1	PropaneIBA 01/2019
1	16S Ribosomal RNAIBA 12/2018
1	Drinking WaterIBA 11/2018
1	SodiumIBA 11/2018
1	InterferonsIBA 10/2018
1	Butyrates (Butyrate)IBA 05/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 05/2018
1	Acetates (Acetic Acid Esters)FDA Link 05/2018
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 01/2018
1	HIV AntibodiesIBA 01/2012
1	Maraviroc FDA Link 12/2011
1	Hepatitis B e AntigensIBA 02/2011

Therapy/Procedure

11	Therapeutics 05/2021 - 09/2005
1	Complementary Therapies (Alternative Medicine) 05/2022
1	Precision Medicine 05/2021
1	Retreatment 01/2021
1	Art Therapy 01/2020
1	Neoadjuvant Therapy 05/2019
1	Time-to-Treatment 01/2019